News

Infection with Nontuberculous Mycobacteria May Increase Risk for Sjogren’s Syndrome

A history of infection with nontuberculous mycobacteria — linked to chronic pulmonary infections, but unable to cause tuberculosis — may increase the risk for primary Sjögren’s syndrome, according to a large nationwide Taiwanese study. “Although the exact disease mechanism behind [Sjögren’s syndrome] remains elusive, a variety of environmental, genetic and hormonal…

Phase 2 Trial Testing 3 Potential Sjögren Therapies Now Enrolling in US, Europe

A Phase 2 clinical trial testing the efficacy and safety of three investigational therapies — filgotinib, GS-9876, and tirabrutinib  — in adults with active Sjögren’s syndrome is recruiting participants. The study (NCT03100942) is being conducted by Gilead Sciences, in collaboration with Galapagos. It is expected to enroll 140 patients with active Sjögren’s…